Vanguard Personalized Indexing Management, LLC Fulcrum Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,266 shares of FULC stock, worth $72,067. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,266Holding current value
$72,067% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding FULC
# of Institutions
121Shares Held
51.9MCall Options Held
48.9KPut Options Held
13.8K-
Ra Capital Management, L.P. Boston, MA10.2MShares$71.8 Million0.61% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$36.9 Million3.64% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.07MShares$35.6 Million0.64% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.82MShares$33.9 Million0.63% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$33.7 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $365M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...